Metaphore Biotechnologies
Metaphore Biotechnologies is a Flagship Pioneering company focused on pioneering the power of mimicry in drug discovery. Their proprietary MIMIC™ platform combines machine learning with molecular mimicry to gain deep insights into molecular interactions and create transformative therapeutics. They are developing next-generation therapeutics for obesity management through a research collaboration with Novo Nordisk, a deal valued at up to $600 million. Metaphore aims to unlock previously inaccessible pharmacological targets and achieve breakthroughs that surpass current medications.
Metaphore Biotechnologies
Metaphore Biotechnologies is a Flagship Pioneering company focused on pioneering the power of mimicry in drug discovery. Their proprietary MIMIC™ platform combines machine learning with molecular mimicry to gain deep insights into molecular interactions and create transformative therapeutics. They are developing next-generation therapeutics for obesity management through a research collaboration with Novo Nordisk, a deal valued at up to $600 million. Metaphore aims to unlock previously inaccessible pharmacological targets and achieve breakthroughs that surpass current medications.